The molecular lab is in a revenue transition period.
Labs face tremendous pressure with decreasing reimbursement and a shrinking workforce.
New technology offers the potential to consolidate and automate workloads, reduce costs, and drive the efficiencies that labs urgently need.
Director of Molecular Pathology
Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System
Frederick S. Nolte, PhD, D(ABMM), F(AAM)
Director of Clinical Laboratories
Medical University of South Carolina
Director of Molecular Pathology
Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System
Director of Molecular Pathology
Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System
Director of Molecular Pathology
Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System
Frederick S. Nolte, PhD, D(ABMM), F(AAM)
Director of Clinical Laboratories
Medical University of South Carolina
Molecular Automation is Changing Clinical Labs
By Julie Kirkwood
Adoption of advanced instruments signals another shift in traditional boundaries and disciplines.
Core planning concepts for lab consolidation
By Jeff Raasch, AIA, LEED AP and Jim Gazvoda, AIA
Consolidated labs can help to improve efficiencies and lead to better patient care.
Lessons in the Core Lab Model
By ADVANCE Staff
Today's changing healthcare landscape has introduced significant challenges to clinical laboratories, such as decreased reimbursement and an increased demand for testing, despite ongoing labor shortages.